Sema3A knockdown decreased proliferation of Lewis lung carcinoma cells (LLCs).
Sema3A knockdown decreased mTORC1 levels and glycolytic activity in LLCs.
Sema3A knockdown sensitized cells to inhibition of oxidative phosphorylation.
Sema3A promotes shift from oxidative phosphorylation to aerobic glycolysis via mTORC1.